As of Jun 23
| -0.12 / -1.37%|
The 3 analysts offering 12-month price forecasts for Immunomedics Inc have a median target of 11.50, with a high estimate of 15.00 and a low estimate of 9.00. The median estimate represents a +33.57% increase from the last price of 8.61.
The current consensus among 3 polled investment analysts is to Buy stock in Immunomedics Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.